The 13 analysts offering 12-month price forecasts for Axsome Therapeutics Inc have a median target of 63.00, with a high estimate of 162.00 and a low estimate of 28.00. The median estimate represents a +48.48% increase from the last price of 42.43.
The current consensus among 13 polled investment analysts is to Buy stock in Axsome Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.07
Reporting Date Nov 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.